|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Trichloronaphthalene | CAS 1321-65-9 | ||
| C10H5Cl3 | RTECS QK4025000 | ||
|
Synonyms & Trade Names Halowax®, Nibren wax, Seekay wax |
DOT ID & Guide |
||
|
Exposure Limits |
NIOSH REL: TWA 5 mg/m3 [skin] | ||
| OSHA PEL: TWA 5 mg/m3 [skin] | |||
| IDLH Unknown See: 1321659 | Conversion | ||
|
Physical Description Colorless to pale-yellow solid with an aromatic odor. |
|||
|
MW: 231.5 |
BP: 579-669°F |
MLT: 199°F |
Sol: Insoluble |
|
VP: <1 mmHg |
IP: ? |
|
Sp.Gr: 1.58 |
|
Fl.P(oc): 392°F |
UEL: ? |
LEL: ? |
|
| Combustible Solid | |||
|
Incompatibilities & Reactivities Strong oxidizers |
|||
|
Measurement Methods NIOSH S128 (II-2) See: NMAM or OSHA Methods |
|
Personal Protection & Sanitation Skin: Prevent skin contact Eyes: Prevent eye contact Wash skin: When contaminated Remove: When wet or contaminated Change: Daily |
First Aid (See procedures) Eye: Irrigate immediately Skin: Soap wash Breathing: Respiratory support Swallow: Medical attention immediately |
|
Important additional information about respirator selection Respirator Recommendations NIOSH/OSHA Up to 50 mg/m3: (APF = 50) Any self-contained breathing apparatus with a full facepiece/(APF = 50) Any supplied-air respirator with a full facepiece Emergency or planned entry into unknown concentrations or IDLH conditions: (APF = 10,000) Any self-contained breathing apparatus that has a full facepiece and is operated in a pressure- demand or other positive-pressure mode/(APF = 10,000) Any supplied-air respirator that has a full facepiece and is operated in a pressure-demand or other positive-pressure mode in combination with an auxiliary self-contained positive-pressure breathing apparatus Escape: (APF = 50) Any air-purifying, full-facepiece respirator (gas mask) with a chin-style, front- or back-mounted organic vapor canister having a high-efficiency particulate filter/Any appropriate escape-type, self-contained breathing apparatus |
|
| Exposure Routes inhalation, skin absorption, ingestion, skin and/or eye contact | |
| Symptoms Anorexia, nausea; dizziness; jaundice, liver injury | |
|
Target Organs
Liver |
|
| See also: INTRODUCTION See ICSC CARD: 0962 See MEDICAL TESTS: 0237 |